BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 26876387)

  • 1. Cannabinoids and autoimmune diseases: A systematic review.
    Katchan V; David P; Shoenfeld Y
    Autoimmun Rev; 2016 Jun; 15(6):513-28. PubMed ID: 26876387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.
    Rodríguez Mesa XM; Moreno Vergara AF; Contreras Bolaños LA; Guevara Moriones N; Mejía Piñeros AL; Santander González SP
    Cannabis Cannabinoid Res; 2021 Jun; 6(3):196-210. PubMed ID: 34030476
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders.
    Ahmed I; Rehman SU; Shahmohamadnejad S; Zia MA; Ahmad M; Saeed MM; Akram Z; Iqbal HMN; Liu Q
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34205169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical cannabis: Another piece in the mosaic of autoimmunity?
    Katz D; Katz I; Porat-Katz BS; Shoenfeld Y
    Clin Pharmacol Ther; 2017 Feb; 101(2):230-238. PubMed ID: 27859024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids as novel anti-inflammatory drugs.
    Nagarkatti P; Pandey R; Rieder SA; Hegde VL; Nagarkatti M
    Future Med Chem; 2009 Oct; 1(7):1333-49. PubMed ID: 20191092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
    Maayah ZH; Takahara S; Ferdaoussi M; Dyck JRB
    Inflamm Res; 2020 Jun; 69(6):549-558. PubMed ID: 32239248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Marihuana and cannobinoids as medicaments].
    Tkaczyk M; Florek E; Piekoszewski W
    Przegl Lek; 2012; 69(10):1095-7. PubMed ID: 23421098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
    Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
    Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis derivatives and pain. A small role for delta9-tetrahydrocannabinol (THC) in some forms of multiple sclerosis.
    Prescrire Int; 2009 Oct; 18(103):226. PubMed ID: 19882800
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of Cannabinoids on T-cell Function and Resistance to Infection.
    Eisenstein TK; Meissler JJ
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):204-16. PubMed ID: 25876735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of cannabinoid-based drugs.
    Klein TW; Newton CA
    Adv Exp Med Biol; 2007; 601():395-413. PubMed ID: 17713029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joints for joints: cannabinoids in the treatment of rheumatoid arthritis.
    Lowin T; Schneider M; Pongratz G
    Curr Opin Rheumatol; 2019 May; 31(3):271-278. PubMed ID: 30920973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
    Bazinski H; Jensen HB; Stenager E
    Ugeskr Laeger; 2015 May; 177(20):956-60. PubMed ID: 26535431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
    Basinski H; Jensen HB; Stenager E
    Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice-A Review.
    Sirbu CA; Georgescu R; Pleşa FC; Paunescu A; Marilena Ţânţu M; Nicolae AC; Caloianu I; Mitrica M
    Am J Ther; 2023 May; 30(3):e220-e231. PubMed ID: 37278703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Cannabinoids in Neuropathic Pain: An Updated Review.
    Arthur P; Kalvala AK; Surapaneni SK; Singh MS
    Crit Rev Ther Drug Carrier Syst; 2024; 41(1):1-33. PubMed ID: 37824417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.
    Braun A; Engel T; Aguilar-Pimentel JA; Zimmer A; Jakob T; Behrendt H; Mempel M
    Immunobiology; 2011 Apr; 216(4):466-76. PubMed ID: 21056512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The cannabinoid system and pain: towards new drugs?].
    Beltramo M
    J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke.
    Pini A; Mannaioni G; Pellegrini-Giampietro D; Passani MB; Mastroianni R; Bani D; Masini E
    Curr Drug Targets; 2012 Jun; 13(7):984-93. PubMed ID: 22420307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective agents: cannabinoids.
    Sánchez AJ; García-Merino A
    Clin Immunol; 2012 Jan; 142(1):57-67. PubMed ID: 21420365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.